Prot# 20-04-003: Phz 4, Rndmzd, Opn-Lbl, Cmprtv, Mltctr Study to Assess S&E of Induction Agents Alemtuzumab(Campath 1H), Basiliximab(Simulect) or Rabbit Anti-Thymocyte Globulin(Thymoglobulin) in Combt'n w/Tacrolimus(Prograf), Mycophenolate Mofetil(Cellcep

Project: Research project

Project Details

StatusFinished
Effective start/end date9/19/05 → 12/31/09

Funding

  • Astellas Pharma US, Inc (20-04-003)